FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients Pharmacy Times
FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy
FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy Ophthalmology Times Europe
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer The American Journal of Managed Care
Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo
Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo Contemporary OB/GYN